DK80989A - Anvendelse af quinolizin- og quinolizinon-derivater ved fremstilling af laegemidler - Google Patents
Anvendelse af quinolizin- og quinolizinon-derivater ved fremstilling af laegemidlerInfo
- Publication number
- DK80989A DK80989A DK080989A DK80989A DK80989A DK 80989 A DK80989 A DK 80989A DK 080989 A DK080989 A DK 080989A DK 80989 A DK80989 A DK 80989A DK 80989 A DK80989 A DK 80989A
- Authority
- DK
- Denmark
- Prior art keywords
- derivatives
- quinolizinon
- quinolizin
- preparation
- medicinal products
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Nutrition Science (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP88400418 | 1988-02-23 | ||
EP88400416A EP0329903A1 (en) | 1988-02-23 | 1988-02-23 | Use of quinolizinone and quinolizine derivatives in the manufacture of medicaments for the treatment of glaucoma |
EP88400415A EP0329902A1 (en) | 1988-02-23 | 1988-02-23 | Use of quinolizinone and quinolizine derivatives in the manufacture of medicaments for the treatment of psychosis |
EP88400416 | 1988-02-23 | ||
EP88400415 | 1988-02-23 | ||
EP88400417 | 1988-02-23 | ||
EP88400417A EP0329904A1 (en) | 1988-02-23 | 1988-02-23 | Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of anxiety |
EP88400418A EP0329905A1 (en) | 1988-02-23 | 1988-02-23 | Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for increasing gastric motility |
US18563188A | 1988-04-26 | 1988-04-26 | |
US18563188 | 1988-04-26 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK80989D0 DK80989D0 (da) | 1989-02-22 |
DK80989A true DK80989A (da) | 1989-08-24 |
DK175643B1 DK175643B1 (da) | 2005-01-03 |
Family
ID=27513624
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK198900809A DK175643B1 (da) | 1988-02-23 | 1989-02-22 | Anvendelse af quinolizin- og quinolizinon-derivater ved fremstilling af lægemidler |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0329932B1 (da) |
JP (1) | JPH02288880A (da) |
KR (1) | KR890013018A (da) |
AT (1) | ATE129153T1 (da) |
AU (1) | AU624115B2 (da) |
DE (1) | DE68924545T2 (da) |
DK (1) | DK175643B1 (da) |
ES (1) | ES2080727T3 (da) |
GR (1) | GR3018299T3 (da) |
IE (1) | IE72504B1 (da) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69004924T2 (de) * | 1989-04-21 | 1994-05-19 | Sandoz Ag | Therapeutische verwendung von 5-ht3-rezeptor-antagonisten. |
EP0492020A1 (en) * | 1990-12-21 | 1992-07-01 | Merrell Dow Pharmaceuticals Inc. | Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and related compounds for treating cognitive disorders |
KR100287933B1 (ko) * | 1992-02-24 | 2001-05-02 | 슈테펜엘.네스비트 | 5-ht3-수용체 길항제로서의 2,6-메타노-2h-퀴놀리진 유도체,이의 제조방법 및 이를 포함하는 약제학적 조성물 |
US5508287A (en) * | 1992-02-24 | 1996-04-16 | Merrell Pharmaceuticals Inc. | 2,6-methano-2H-quinolizin derivative as 5-HT3 -receptor antagonist |
MX2009010174A (es) * | 2007-03-23 | 2009-10-12 | Abbott Lab | Derivados de aza-adamantano ester y carbamato y metodos de uso de los mismos. |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2531083B1 (fr) * | 1982-06-29 | 1986-11-28 | Sandoz Sa | Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments |
CH664567A5 (de) * | 1983-08-26 | 1988-03-15 | Sandoz Ag | Aromatische carbonsaeure- und sulfonsaeureester oder -amide. |
FR2557110B1 (fr) * | 1983-12-23 | 1989-11-24 | Sandoz Sa | Nouveaux derives d'amines cycliques, leur preparation et leur utilisation comme medicaments |
DE3680123D1 (en) * | 1985-01-23 | 1991-08-14 | Glaxo Group Ltd | Tetrahydrocarbazolonderivate. |
DE3688296T2 (de) * | 1985-03-14 | 1993-11-04 | Beecham Group Plc | Arzneimittel zur behandlung von erbrechen. |
GB8525913D0 (en) * | 1985-10-21 | 1985-11-27 | Beecham Group Plc | Compounds |
GB8511988D0 (en) * | 1985-05-11 | 1985-06-19 | Beecham Group Plc | Compounds |
GB8520616D0 (en) * | 1985-08-16 | 1985-09-25 | Beecham Group Plc | Compounds |
GB8523211D0 (en) * | 1985-09-19 | 1985-10-23 | Beecham Group Plc | Compounds |
EP0220011A3 (en) * | 1985-10-12 | 1990-01-03 | Beecham Group Plc | Use of azabicloalkylbenzamides in the treatment of gastrointestinal motility disorders, migraine, emesis, cluster headaches, trigeminal neuralgia and arrhythmia |
US4910193A (en) * | 1985-12-16 | 1990-03-20 | Sandoz Ltd. | Treatment of gastrointestinal disorders |
ZA878096B (en) * | 1986-11-03 | 1988-04-26 | Merrell Dow Pharmaceuticals Inc. | Esters of hexahydro-8-hydroxy-2,6-methano-2h-quinolizin-3(4h)-one and related compounds |
EP0330788A1 (en) * | 1988-03-01 | 1989-09-06 | Merrell Dow Pharmaceuticals Inc. | Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of cardiac arrhythmia |
-
1989
- 1989-01-11 DE DE68924545T patent/DE68924545T2/de not_active Expired - Lifetime
- 1989-01-11 AT AT89100392T patent/ATE129153T1/de not_active IP Right Cessation
- 1989-01-11 EP EP89100392A patent/EP0329932B1/en not_active Expired - Lifetime
- 1989-01-11 ES ES89100392T patent/ES2080727T3/es not_active Expired - Lifetime
- 1989-02-22 IE IE56489A patent/IE72504B1/en not_active IP Right Cessation
- 1989-02-22 DK DK198900809A patent/DK175643B1/da not_active IP Right Cessation
- 1989-02-22 AU AU30214/89A patent/AU624115B2/en not_active Expired
- 1989-02-22 KR KR1019890002061A patent/KR890013018A/ko not_active Application Discontinuation
- 1989-02-23 JP JP1042012A patent/JPH02288880A/ja active Pending
-
1995
- 1995-12-05 GR GR950403417T patent/GR3018299T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK175643B1 (da) | 2005-01-03 |
DE68924545T2 (de) | 1996-03-21 |
AU624115B2 (en) | 1992-06-04 |
EP0329932A3 (en) | 1992-08-05 |
JPH02288880A (ja) | 1990-11-28 |
GR3018299T3 (en) | 1996-03-31 |
IE72504B1 (en) | 1997-04-23 |
DK80989D0 (da) | 1989-02-22 |
EP0329932B1 (en) | 1995-10-18 |
AU3021489A (en) | 1989-08-24 |
EP0329932A2 (en) | 1989-08-30 |
IE890564L (en) | 1989-08-23 |
KR890013018A (ko) | 1989-09-20 |
ES2080727T3 (es) | 1996-02-16 |
ATE129153T1 (de) | 1995-11-15 |
DE68924545D1 (de) | 1995-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT49113A (en) | Process for producing 2-/2-hydroxy-3-phenoxy-propyl-amino/-ethyl-phenoxy-methyl-amido derivatives and pharmaceutical compositions containing them as active components | |
DE3585185D1 (de) | Immunogene konjugate der lt-b enterotoxinuntereinheit von e. coli und kapselige polymere. | |
NO156752B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(1-piperidinylalkyl)-4hpyrido(1,2-a)pyrimidin-4-0n derivater | |
NO172344C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte flavonoidforbindelser og salter | |
NO166362C (no) | Analogifremgangsmaate for fremstilling av nye terapeutisk aktive polyaminderivater. | |
DK217588D0 (da) | 17beta-(cyclopropylamino)-androst-5-en-3beta-olderivater, deres fremstilling og anvendelse som laegemidler | |
DK336688A (da) | Nucleosider od fremgangsmaade til fremstilling deraf | |
NO171412C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater | |
FI903225A0 (fi) | Menetelmä valmistaa terapeuttisesti arvokasta 5,11-dihydro-6H-dipyrido/3,2-b:2',3'-e/ /1,4/diatsepin-6-onia | |
GR3001559T3 (en) | Polyoxygenated labdane derivatives, process for their preparation and their use as medicaments | |
FI93106C (fi) | Menetelmä lääkeaineina käyttökelpoisten 2-iminobentsotiatsoliinijohdannaisten valmistamiseksi | |
DK80989D0 (da) | Anvendelse af quinolizin- og quinolizinon-derivater ved fremstilling af laegemidler | |
ATE67495T1 (de) | 4-(1,2,5,6-tetrahydro-1-alkyl-3-pyridinyl)-2thiazolamine und 4-(hexahydro-1-alkyl-3pyridinyl)-2-thiazolamine. | |
IT8921893A0 (it) | Procedimento per la produzione di impiallacciatura artificiale ad imitazione della radica, mediante bruciature. | |
FI895983A0 (fi) | Menetelmä lääkeaineina käyttökelpoisten 2-bentsotiatsoliinijohdannaisten valmistamiseksi | |
NO895195D0 (no) | Fremgangsmaate for fremstilling av piperidinderivater samtmellomprodukter. | |
DK557189D0 (da) | 1,2,3,4-tetrahydro-1,9-acridindiaminer, deres fremstilling og anvendelse som laegemidler | |
NO171211C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner | |
DK429788D0 (da) | Thieno(2,3-beta)thiophen-2-sulfonamid og farmaceutisk praeparat indeholdende en saadan forbindelse | |
DK0415321T3 (da) | Oligodendrocyt-cytotoksisk faktor | |
PT86695A (pt) | Process for the preparation of tetrahydropyridoý3',4':4,5¨pyrr oloý2,3-c¨quinolines and their derivatives | |
FI911282A (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten 3,4-dihydroksi-2,5-dihydrofuranonien valmistamiseksi | |
PT889044E (pt) | Derivados do 5-(heteroaril)alquil-3-oxo-pirido-(1,2-a)benzimidazole-4-carboxamida (pbi) uteis no tratamento de perturbacoes do sistema nervoso central | |
ES2043896T3 (es) | Procedimiento para la preparacion de derivados de tetrahidropiridina. | |
NO882794L (no) | Fremgangsmaate for fremstilling av kalsium-10-propyl-2,8-bis(1h-tetrazol-5-yl)-4h,6h-benzo(1,2-b; 5,4-b')dipyran-4,6-dion. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUP | Patent expired |